ID   NTR1_RAT                Reviewed;         424 AA.
AC   P20789;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   02-OCT-2024, entry version 186.
DE   RecName: Full=Neurotensin receptor type 1;
DE            Short=NT-R-1;
DE            Short=NTR1;
DE   AltName: Full=High-affinity levocabastine-insensitive neurotensin receptor;
DE   AltName: Full=NTRH;
GN   Name=Ntsr1; Synonyms=Ntsr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1694443; DOI=10.1016/0896-6273(90)90137-5;
RA   Tanaka K., Masu M., Nakanishi S.;
RT   "Structure and functional expression of the cloned rat neurotensin
RT   receptor.";
RL   Neuron 4:847-854(1990).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 43-396 IN COMPLEX WITH NEUROTENSIN
RP   FRAGMENT, LIGAND BINDING DOMAIN, AND DISULFIDE BOND.
RX   PubMed=23051748; DOI=10.1038/nature11558;
RA   White J.F., Noinaj N., Shibata Y., Love J., Kloss B., Xu F.,
RA   Gvozdenovic-Jeremic J., Shah P., Shiloach J., Tate C.G., Grisshammer R.;
RT   "Structure of the agonist-bound neurotensin receptor.";
RL   Nature 490:508-513(2012).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 50-390 IN COMPLEX WITH
RP   NEUROTENSIN FRAGMENT, DISULFIDE BOND, SUBCELLULAR LOCATION, TOPOLOGY, AND
RP   FUNCTION.
RX   PubMed=24453215; DOI=10.1073/pnas.1317903111;
RA   Egloff P., Hillenbrand M., Klenk C., Batyuk A., Heine P., Balada S.,
RA   Schlinkmann K.M., Scott D.J., Schutz M., Pluckthun A.;
RT   "Structure of signaling-competent neurotensin receptor 1 obtained by
RT   directed evolution in Escherichia coli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:E655-E662(2014).
RN   [4] {ECO:0007744|PDB:4XEE, ECO:0007744|PDB:4XES}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 43-396, FUNCTION, SUBCELLULAR
RP   LOCATION, TOPOLOGY, DISULFIDE BONDS, DOMAIN, AND MUTAGENESIS OF GLU-166;
RP   LEU-310 AND PHE-358.
RX   PubMed=26205105; DOI=10.1038/ncomms8895;
RA   Krumm B.E., White J.F., Shah P., Grisshammer R.;
RT   "Structural prerequisites for G-protein activation by the neurotensin
RT   receptor.";
RL   Nat. Commun. 6:7895-7895(2015).
CC   -!- FUNCTION: G-protein coupled receptor for the tridecapeptide neurotensin
CC       (NTS) (PubMed:23051748, PubMed:24453215, PubMed:26205105). Signaling is
CC       effected via G proteins that activate a phosphatidylinositol-calcium
CC       second messenger system. Signaling leads to the activation of
CC       downstream MAP kinases and protects cells against apoptosis (By
CC       similarity). {ECO:0000250|UniProtKB:P30989, ECO:0000269|PubMed:1694443,
CC       ECO:0000269|PubMed:23051748, ECO:0000269|PubMed:24453215,
CC       ECO:0000269|PubMed:26205105}.
CC   -!- SUBUNIT: Interacts (palmitoylated form) with GNA11.
CC       {ECO:0000250|UniProtKB:P30989}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1694443,
CC       ECO:0000269|PubMed:24453215, ECO:0000269|PubMed:26205105}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:1694443,
CC       ECO:0000269|PubMed:24453215, ECO:0000269|PubMed:26205105}. Membrane
CC       raft {ECO:0000250|UniProtKB:P30989}. Note=Palmitoylation is required
CC       for localization at CAV1-enriched membrane rafts.
CC       {ECO:0000250|UniProtKB:P30989}.
CC   -!- TISSUE SPECIFICITY: Detected in brain and small intestine.
CC       {ECO:0000269|PubMed:1694443}.
CC   -!- DOMAIN: The ligand binding pocket consists mainly of extracellular
CC       loops ECL2 and ECL3, as well as transmembrane regions TM6 and TM7.
CC       {ECO:0000269|PubMed:23051748, ECO:0000269|PubMed:26205105}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:P30989}.
CC   -!- PTM: Palmitoylated; this is required for normal localization at
CC       membrane rafts and normal GNA11-mediated activation of down-stream
CC       signaling cascades. The palmitoylation level increases in response to
CC       neurotensin treatment. {ECO:0000250|UniProtKB:P30989}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Neurotensin receptor subfamily. NTSR1 sub-subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   PIR; JH0164; JH0164.
DR   RefSeq; NP_001102437.1; NM_001108967.1.
DR   RefSeq; XP_006235850.1; XM_006235788.1.
DR   PDB; 3ZEV; X-ray; 3.00 A; A/B=50-390.
DR   PDB; 4BUO; X-ray; 2.75 A; A/B=50-390.
DR   PDB; 4BV0; X-ray; 3.10 A; A/B=50-390.
DR   PDB; 4BWB; X-ray; 3.57 A; A/B=50-390.
DR   PDB; 4GRV; X-ray; 2.80 A; A=43-268, A=300-396.
DR   PDB; 4XEE; X-ray; 2.90 A; A=43-396.
DR   PDB; 4XES; X-ray; 2.60 A; A=43-396.
DR   PDB; 5T04; X-ray; 3.30 A; A=43-268, A=297-396.
DR   PDB; 6YVR; X-ray; 2.46 A; AAA/BBB=50-371.
DR   PDB; 6Z4Q; X-ray; 2.92 A; AAA=50-371.
DR   PDB; 6Z4S; X-ray; 2.71 A; AAA=50-371.
DR   PDB; 6Z4V; X-ray; 2.60 A; AAA=50-371.
DR   PDB; 6Z66; X-ray; 3.19 A; AAA=50-371.
DR   PDB; 6Z8N; X-ray; 2.80 A; AAA=50-371.
DR   PDB; 6ZA8; X-ray; 2.72 A; AAA=50-371.
DR   PDB; 6ZIN; X-ray; 2.64 A; AAA=50-371.
DR   PDB; 7L0P; EM; 4.10 A; C=50-390.
DR   PDB; 7L0Q; EM; 4.30 A; C=50-390.
DR   PDB; 7L0R; EM; 4.20 A; C=50-390.
DR   PDB; 7L0S; EM; 4.50 A; C=50-390.
DR   PDB; 8FMZ; EM; 2.59 A; A=43-420.
DR   PDB; 8FN0; EM; 2.89 A; A=43-424.
DR   PDB; 8FN1; EM; 2.88 A; A=39-424.
DR   PDBsum; 3ZEV; -.
DR   PDBsum; 4BUO; -.
DR   PDBsum; 4BV0; -.
DR   PDBsum; 4BWB; -.
DR   PDBsum; 4GRV; -.
DR   PDBsum; 4XEE; -.
DR   PDBsum; 4XES; -.
DR   PDBsum; 5T04; -.
DR   PDBsum; 6YVR; -.
DR   PDBsum; 6Z4Q; -.
DR   PDBsum; 6Z4S; -.
DR   PDBsum; 6Z4V; -.
DR   PDBsum; 6Z66; -.
DR   PDBsum; 6Z8N; -.
DR   PDBsum; 6ZA8; -.
DR   PDBsum; 6ZIN; -.
DR   PDBsum; 7L0P; -.
DR   PDBsum; 7L0Q; -.
DR   PDBsum; 7L0R; -.
DR   PDBsum; 7L0S; -.
DR   PDBsum; 8FMZ; -.
DR   PDBsum; 8FN0; -.
DR   PDBsum; 8FN1; -.
DR   AlphaFoldDB; P20789; -.
DR   EMDB; EMD-23099; -.
DR   EMDB; EMD-23100; -.
DR   EMDB; EMD-23101; -.
DR   EMDB; EMD-23102; -.
DR   EMDB; EMD-29301; -.
DR   EMDB; EMD-29302; -.
DR   EMDB; EMD-29303; -.
DR   SMR; P20789; -.
DR   DIP; DIP-59956N; -.
DR   IntAct; P20789; 2.
DR   STRING; 10116.ENSRNOP00000035997; -.
DR   BindingDB; P20789; -.
DR   ChEMBL; CHEMBL3027; -.
DR   GuidetoPHARMACOLOGY; 309; -.
DR   GlyCosmos; P20789; 3 sites, No reported glycans.
DR   GlyGen; P20789; 3 sites.
DR   iPTMnet; P20789; -.
DR   PhosphoSitePlus; P20789; -.
DR   SwissPalm; P20789; -.
DR   PaxDb; 10116-ENSRNOP00000035997; -.
DR   Ensembl; ENSRNOT00000039780.4; ENSRNOP00000035997.2; ENSRNOG00000028708.4.
DR   Ensembl; ENSRNOT00055001811; ENSRNOP00055001411; ENSRNOG00055001097.
DR   Ensembl; ENSRNOT00060001917; ENSRNOP00060001124; ENSRNOG00060001326.
DR   Ensembl; ENSRNOT00065023983; ENSRNOP00065018686; ENSRNOG00065014521.
DR   GeneID; 366274; -.
DR   KEGG; rno:366274; -.
DR   UCSC; RGD:1306076; rat.
DR   AGR; RGD:1306076; -.
DR   CTD; 4923; -.
DR   RGD; 1306076; Ntsr1.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01120000271823; -.
DR   HOGENOM; CLU_009579_6_5_1; -.
DR   InParanoid; P20789; -.
DR   OMA; CLCPLWG; -.
DR   OrthoDB; 3471593at2759; -.
DR   PhylomeDB; P20789; -.
DR   TreeFam; TF337167; -.
DR   Reactome; R-RNO-375276; Peptide ligand-binding receptors.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   EvolutionaryTrace; P20789; -.
DR   PRO; PR:P20789; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000028708; Expressed in ovary and 13 other cell types or tissues.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0044309; C:neuron spine; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0032280; C:symmetric synapse; IDA:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0016492; F:G protein-coupled neurotensin receptor activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0008344; P:adult locomotory behavior; ISO:RGD.
DR   GO; GO:0070779; P:D-aspartate import across plasma membrane; IDA:RGD.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IMP:RGD.
DR   GO; GO:0071545; P:inositol phosphate catabolic process; IMP:RGD.
DR   GO; GO:0098712; P:L-glutamate import across plasma membrane; IDA:RGD.
DR   GO; GO:0007612; P:learning; IMP:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0051280; P:negative regulation of release of sequestered calcium ion into cytosol; IMP:RGD.
DR   GO; GO:0003085; P:negative regulation of systemic arterial blood pressure; IMP:RGD.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0090238; P:positive regulation of arachidonic acid secretion; IMP:RGD.
DR   GO; GO:0014054; P:positive regulation of gamma-aminobutyric acid secretion; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0014049; P:positive regulation of glutamate secretion; IMP:RGD.
DR   GO; GO:0097151; P:positive regulation of inhibitory postsynaptic potential; IMP:RGD.
DR   GO; GO:0060732; P:positive regulation of inositol phosphate biosynthetic process; IMP:RGD.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IMP:RGD.
DR   GO; GO:0003254; P:regulation of membrane depolarization; IMP:RGD.
DR   GO; GO:0043576; P:regulation of respiratory gaseous exchange; IMP:RGD.
DR   GO; GO:0033993; P:response to lipid; IDA:RGD.
DR   GO; GO:0001659; P:temperature homeostasis; IMP:RGD.
DR   CDD; cd15355; 7tmA_NTSR1; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR003985; NT1_rcpt.
DR   InterPro; IPR003984; NT_rcpt.
DR   PANTHER; PTHR24243; G-PROTEIN COUPLED RECEPTOR; 1.
DR   PANTHER; PTHR24243:SF9; NEUROTENSIN RECEPTOR TYPE 1; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR01479; NEUROTENSINR.
DR   PRINTS; PR01480; NEUROTENSN1R.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Lipoprotein; Membrane; Palmitate; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..424
FT                   /note="Neurotensin receptor type 1"
FT                   /id="PRO_0000069948"
FT   TOPO_DOM        1..68
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:24453215"
FT   TRANSMEM        69..89
FT                   /note="Helical; Name=1"
FT   TOPO_DOM        90..103
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24453215"
FT   TRANSMEM        104..123
FT                   /note="Helical; Name=2"
FT   TOPO_DOM        124..143
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:24453215"
FT   TRANSMEM        144..165
FT                   /note="Helical; Name=3"
FT   TOPO_DOM        166..185
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24453215"
FT   TRANSMEM        186..206
FT                   /note="Helical; Name=4"
FT   TOPO_DOM        207..235
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:24453215"
FT   TRANSMEM        236..260
FT                   /note="Helical; Name=5"
FT   TOPO_DOM        261..308
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24453215"
FT   TRANSMEM        309..330
FT                   /note="Helical; Name=6"
FT   TOPO_DOM        331..348
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:24453215"
FT   TRANSMEM        349..369
FT                   /note="Helical; Name=7"
FT   TOPO_DOM        370..424
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24453215"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          326..349
FT                   /note="Neurotensin binding"
FT   REGION          397..424
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        403..424
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           386
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P30989"
FT   LIPID           388
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P30989"
FT   CARBOHYD        4
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        38
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        42
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        142..225
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521,
FT                   ECO:0000269|PubMed:23051748, ECO:0000269|PubMed:24453215"
FT   MUTAGEN         166
FT                   /note="E->A: Abolishes signaling via G-proteins; when
FT                   associated with A-310 and A-358."
FT                   /evidence="ECO:0000269|PubMed:26205105"
FT   MUTAGEN         310
FT                   /note="L->A: Abolishes signaling via G-proteins; when
FT                   associated with A-166 and A-358."
FT                   /evidence="ECO:0000269|PubMed:26205105"
FT   MUTAGEN         358
FT                   /note="F->A: Abolishes signaling via G-proteins; when
FT                   associated with A-166 and A-310."
FT                   /evidence="ECO:0000269|PubMed:26205105"
FT   HELIX           53..55
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   TURN            61..63
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   HELIX           64..89
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   HELIX           102..127
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   TURN            128..130
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   HELIX           138..172
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   HELIX           174..180
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   HELIX           183..200
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   HELIX           202..205
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   STRAND          208..212
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   STRAND          215..217
FT                   /evidence="ECO:0007829|PDB:4XES"
FT   HELIX           220..222
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   STRAND          223..227
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   HELIX           231..245
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   HELIX           247..265
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   HELIX           298..300
FT                   /evidence="ECO:0007829|PDB:4XES"
FT   HELIX           304..333
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   TURN            336..338
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   HELIX           341..369
FT                   /evidence="ECO:0007829|PDB:8FMZ"
FT   STRAND          371..373
FT                   /evidence="ECO:0007829|PDB:4XES"
FT   HELIX           376..381
FT                   /evidence="ECO:0007829|PDB:4XES"
SQ   SEQUENCE   424 AA;  47055 MW;  A9C2F7EAF8D9BCD3 CRC64;
     MHLNSSVPQG TPGEPDAQPF SGPQSEMEAT FLALSLSNGS GNTSESDTAG PNSDLDVNTD
     IYSKVLVTAI YLALFVVGTV GNSVTAFTLA RKKSLQSLQS TVHYHLGSLA LSDLLILLLA
     MPVELYNFIW VHHPWAFGDA GCRGYYFLRD ACTYATALNV ASLSVERYLA ICHPFKAKTL
     MSRSRTKKFI SAIWLASALL AIPMLFTMGL QNRSGDGTHP GGLVCTPIVD TATVKVVIQV
     NTFMSFLFPM LVISILNTVI ANKLTVMVHQ AAEQGRVCTV GTHNGLEHST FNMTIEPGRV
     QALRHGVLVL RAVVIAFVVC WLPYHVRRLM FCYISDEQWT TFLFDFYHYF YMLTNALFYV
     SSAINPILYN LVSANFRQVF LSTLACLCPG WRHRRKKRPT FSRKPNSMSS NHAFSTSATR
     ETLY
//
